Related references
Note: Only part of the references are listed.Dynamics of Behavioral Disorders in Transgenic Mice with Modeled Alzheimer's Disease
I. I. Semina et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Presenilin-1 Knockin Mice Reveal Loss-of-Function Mechanism for Familial Alzheimer's Disease
Dan Xia et al.
NEURON (2015)
The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model
Xiao-rui Cheng et al.
AGEING RESEARCH REVIEWS (2014)
Single App knock-in mouse models of Alzheimer's disease
Takashi Saito et al.
NATURE NEUROSCIENCE (2014)
Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases
Jacob I. Ayers et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Reversible Pathologic and Cognitive Phenotypes in an Inducible Model of Alzheimer-Amyloidosis
Tatiana Melnikova et al.
JOURNAL OF NEUROSCIENCE (2013)
Trafficking and Proteolytic Processing of APP
Christian Haass et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Premature death and neurologic abnormalities in transgenic mice expressing a mutant huntingtin exon-2 fragment
Andrew T. N. Tebbenkamp et al.
HUMAN MOLECULAR GENETICS (2011)
Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative
Andrew T. N. Tebbenkamp et al.
HUMAN MOLECULAR GENETICS (2011)
An Overview of APP Processing Enzymes and Products
Vivian W. Chow et al.
NEUROMOLECULAR MEDICINE (2010)
BRI2 (ITM2b) inhibits Aβ deposition in vivo
Jungsu Kim et al.
JOURNAL OF NEUROSCIENCE (2008)
Rodent Aβ modulates the solubility and distribution of amyloid deposits in transgenic mice
Joanna L. Jankowsky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Persistent amyloidosis following suppression of Aβ production in a transgenic model of Alzheimer disease
JL Jankowsky et al.
PLOS MEDICINE (2005)
Aβ42 is essential for parenchymal and vascular amyloid deposition in mice
E McGowan et al.
NEURON (2005)
Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease
JL Jankowsky et al.
JOURNAL OF NEUROSCIENCE (2005)
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase
JL Jankowsky et al.
HUMAN MOLECULAR GENETICS (2004)
Normal cognitive behavior in two distinct congenic lines of transgenic mice hyperexpressing mutant APPSWE
AV Savonenko et al.
NEUROBIOLOGY OF DISEASE (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Aβ deposition does not cause the aggregation of endogenous tau in transgenic mice
GL Xu et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2002)
FAD mutant PS-1 gene-targeted mice:: Increased Aβ42 and Aβ deposition without APP overproduction
DG Flood et al.
NEUROBIOLOGY OF AGING (2002)
Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice
C Lesuisse et al.
HUMAN MOLECULAR GENETICS (2001)
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies
JL Jankowsky et al.
BIOMOLECULAR ENGINEERING (2001)
Variant Alzheimer disease with spastic paraparesis: Neuropathological phenotype
A Verkkoniemi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
BACE1 is the major β-secretase for generation of Aβ peptides by neurons
HB Cai et al.
NATURE NEUROSCIENCE (2001)
β-Amyloid precursor polypeptide in SAMP8 mice affects learning and memory
JE Morley et al.
PEPTIDES (2000)
Variant Alzheimer's disease with spastic paraparesis - Clinical characterization
A Verkkoniemi et al.
NEUROLOGY (2000)
Share Paper
